Cns Pharmaceuticals (CNSP) Income Statement (2018 - 2026)
Income Statement report data from Mar 31, 2018 to Mar 31, 2026 for Cns Pharmaceuticals (CNSP).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||||||||||
Research And Development | 3.54M (+11.67%) | 3.17M (+44.09%) | 2.20M (+88.03%) | 1.17M (-63.89%) | 3.24M (+116.00%) | 1.50M (-64.62%) | 4.24M (+278.57%) | 1.12M (-53.91%) | 2.43M (-43.09%) | 4.27M (+25.22%) | 3.41M (+19.65%) | 2.85M (-20.17%) | 3.57M (+19.80%) | 2.98M (+34.84%) | 2.21M (-0.45%) | 2.22M (+17.46%) | 1.89M (-19.92%) | 2.36M (-8.53%) | 2.58M (-3.01%) | 2.66M (+20.36%) | 2.21M (+15.71%) | 1.91M (+83.65%) | 1.04M (-30.20%) | 1.49M (+144.26%) | 610K (-57.64%) | 1.44M (+336.36%) | 330K (+725.00%) | 40K (-20.00%) | 50K (+150.00%) | 20K | - | - | - |
Selling General And Administrative | 1.43M (-49.29%) | 2.82M (+166.04%) | 1.06M (-14.52%) | 1.24M (+13.76%) | 1.09M (-35.88%) | 1.70M (+23.19%) | 1.38M (-2.13%) | 1.41M (+27.03%) | 1.11M (0.00%) | 1.11M (-0.89%) | 1.12M (-5.08%) | 1.18M (-13.24%) | 1.36M (-36.74%) | 2.15M (+77.69%) | 1.21M (-9.70%) | 1.34M (+6.35%) | 1.26M (+40.00%) | 900K (-27.42%) | 1.24M (+7.83%) | 1.15M (-17.86%) | 1.40M (+28.44%) | 1.09M (+12.37%) | 970K (-1.02%) | 980K (-27.94%) | 1.36M (+24.77%) | 1.09M (+194.59%) | 370K (0.00%) | 370K (+146.67%) | 150K (-78.57%) | 700K (+311.76%) | 170K | - | - |
Operating Expenses | 4.98M (-16.86%) | 5.99M (+84.31%) | 3.25M (+34.85%) | 2.41M (-44.47%) | 4.34M (+35.63%) | 3.20M (-43.16%) | 5.63M (+122.53%) | 2.53M (-28.53%) | 3.54M (-34.20%) | 5.38M (+18.76%) | 4.53M (+12.41%) | 4.03M (-18.26%) | 4.93M (-3.90%) | 5.13M (+50.00%) | 3.42M (-3.93%) | 3.56M (+13.02%) | 3.15M (-3.08%) | 3.25M (-14.70%) | 3.81M (0.00%) | 3.81M (+5.54%) | 3.61M (+20.33%) | 3.00M (+49.25%) | 2.01M (-18.62%) | 2.47M (+25.38%) | 1.97M (-21.83%) | 2.52M (+260.00%) | 700K (+66.67%) | 420K (+110.00%) | 200K (-71.83%) | 710K (+317.65%) | 170K | - | - |
Depreciation And Amortization | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K | - | - | - | 10K | - | - | - | 10K | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||||||||||||||||||
Operating Income | -4.98M (-16.86%) | -5.99M (+84.31%) | -3.25M (+34.85%) | -2.41M (-44.47%) | -4.34M (+35.63%) | -3.20M (-43.16%) | -5.63M (+122.53%) | -2.53M (-28.53%) | -3.54M (-34.20%) | -5.38M (+18.76%) | -4.53M (+12.41%) | -4.03M (-18.26%) | -4.93M (-3.90%) | -5.13M (+50.00%) | -3.42M (-3.93%) | -3.56M (+13.02%) | -3.15M (-3.08%) | -3.25M (-14.70%) | -3.81M (0.00%) | -3.81M (+5.54%) | -3.61M (+20.33%) | -3.00M (+49.25%) | -2.01M (-18.62%) | -2.47M (+25.38%) | -1.97M (-21.83%) | -2.52M (+260.00%) | -700.00K (+66.67%) | -420.00K (+110.00%) | -200.00K (-71.83%) | -710.00K (+317.65%) | -170.00K | - | - |
Ebit | -4.98M (-16.86%) | -5.99M (+84.31%) | -3.25M (+34.85%) | -2.41M (-44.47%) | -4.34M (+35.63%) | -3.20M (-43.16%) | -5.63M (+122.53%) | -2.53M (-28.53%) | -3.54M (-34.20%) | -5.38M (+18.76%) | -4.53M (+12.41%) | -4.03M (-18.26%) | -4.93M (-3.90%) | -5.13M (+50.00%) | -3.42M (-3.93%) | -3.56M (+13.02%) | -3.15M (-3.08%) | -3.25M (-14.70%) | -3.81M (0.00%) | -3.81M (+5.54%) | -3.61M (+20.33%) | -3.00M (+49.25%) | -2.01M (-18.62%) | -2.47M (+25.38%) | -1.97M (-21.83%) | -2.52M (+260.00%) | -700.00K (+66.67%) | -420.00K (+110.00%) | -200.00K (+42.86%) | -140.00K (-17.65%) | -170.00K (-34.62%) | -260.00K (-16.13%) | -310.00K |
EBITDA | -4.97M (-17.99%) | -6.06M (+88.20%) | -3.22M (+35.86%) | -2.37M (-45.39%) | -4.34M (+34.78%) | -3.22M (-42.50%) | -5.60M (+121.34%) | -2.53M (-28.53%) | -3.54M (-34.44%) | -5.40M (+19.47%) | -4.52M (+12.44%) | -4.02M (-18.46%) | -4.93M (-3.90%) | -5.13M (+50.00%) | -3.42M (-3.93%) | -3.56M (+13.02%) | -3.15M (-2.78%) | -3.24M (-14.96%) | -3.81M (0.00%) | -3.81M (+5.54%) | -3.61M (+20.74%) | -2.99M (+48.76%) | -2.01M (-18.62%) | -2.47M (+25.38%) | -1.97M (-21.51%) | -2.51M (+258.57%) | -700.00K (+66.67%) | -420.00K (+110.00%) | -200.00K (+53.85%) | -130.00K (-27.78%) | -180.00K (-30.77%) | -260.00K (-16.13%) | -310.00K |
Other Income / Expenses | |||||||||||||||||||||||||||||||||
Interest Expense | 10K | - | - | - | 10K | - | - | - | 10K | - | - | - | 10K | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K (0.00%) | 10K (0.00%) | 10K (-50.00%) | 20K (+100.00%) | 10K | - | - |
Net Interest Income | - | - | - | - | - | 10K | - | - | -10.00K | - | - | - | -10.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | -10.00K (0.00%) | -10.00K (0.00%) | -10.00K (-50.00%) | -20.00K (+100.00%) | -10.00K | - | - |
Other Non Operating Income | 40K (-71.43%) | 140K (+366.67%) | 30K (0.00%) | 30K (-25.00%) | 40K (0.00%) | 40K (+100.00%) | 20K | - | - | 10K (0.00%) | 10K | - | -10.00K (0.00%) | -10.00K | - | - | - | -10.00K | - | - | - | - | - | - | - | -40.00K (+300.00%) | -10.00K (-50.00%) | -20.00K | - | -6.51M | - | - | - |
Net Income | |||||||||||||||||||||||||||||||||
Net Income From Continuing Operations | -4.94M (-17.11%) | -5.96M (+85.09%) | -3.22M (+35.86%) | -2.37M (-44.88%) | -4.30M (+35.22%) | -3.18M (-43.32%) | -5.61M (+121.74%) | -2.53M (-28.53%) | -3.54M (-34.20%) | -5.38M (+19.03%) | -4.52M (+12.44%) | -4.02M (-18.46%) | -4.93M (-4.09%) | -5.14M (+50.29%) | -3.42M (-4.20%) | -3.57M (+13.33%) | -3.15M (-3.08%) | -3.25M (-14.70%) | -3.81M (0.00%) | -3.81M (+5.54%) | -3.61M (+20.33%) | -3.00M (+49.25%) | -2.01M (-18.62%) | -2.47M (+25.38%) | -1.97M (-22.13%) | -2.53M (+256.34%) | -710.00K (+65.12%) | -430.00K (+104.76%) | -210.00K (-96.83%) | -6.63M (+3389.47%) | -190.00K (-26.92%) | -260.00K (-16.13%) | -310.00K |
Net Income | -4.94M (-17.11%) | -5.96M (+85.09%) | -3.22M (+35.86%) | -2.37M (-44.88%) | -4.30M (+35.22%) | -3.18M (-43.32%) | -5.61M (+121.74%) | -2.53M (-28.53%) | -3.54M (-34.20%) | -5.38M (+19.03%) | -4.52M (+12.44%) | -4.02M (-18.46%) | -4.93M (-4.09%) | -5.14M (+50.29%) | -3.42M (-4.20%) | -3.57M (+13.33%) | -3.15M (-3.08%) | -3.25M (-14.70%) | -3.81M (0.00%) | -3.81M (+5.54%) | -3.61M (+20.33%) | -3.00M (+49.25%) | -2.01M (-18.62%) | -2.47M (+25.38%) | -1.97M (-22.13%) | -2.53M (+256.34%) | -710.00K (+65.12%) | -430.00K (+104.76%) | -210.00K (-96.83%) | -6.63M (+3389.47%) | -190.00K (-26.92%) | -260.00K (-16.13%) | -310.00K |